NOVO NORDISK A/S-B (NOV.DE) Fundamental Analysis & Valuation

FRA:NOV • DK0062498333

Current stock price

31.76 EUR
-0.49 (-1.52%)
Last:

This NOV.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. NOV.DE Profitability Analysis

1.1 Basic Checks

  • NOV had positive earnings in the past year.
  • NOV had a positive operating cash flow in the past year.
  • In the past 5 years NOV has always been profitable.
  • NOV had a positive operating cash flow in each of the past 5 years.
NOV.DE Yearly Net Income VS EBIT VS OCF VS FCFNOV.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

1.2 Ratios

  • NOV has a Return On Assets of 18.87%. This is amongst the best in the industry. NOV outperforms 98.04% of its industry peers.
  • NOV has a Return On Equity of 52.79%. This is amongst the best in the industry. NOV outperforms 92.16% of its industry peers.
  • With an excellent Return On Invested Capital value of 30.79%, NOV belongs to the best of the industry, outperforming 94.12% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for NOV is significantly above the industry average of 17.40%.
  • The 3 year average ROIC (43.61%) for NOV is well above the current ROIC(30.79%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 18.87%
ROE 52.79%
ROIC 30.79%
ROA(3y)22.39%
ROA(5y)22.95%
ROE(3y)67.23%
ROE(5y)67.14%
ROIC(3y)43.61%
ROIC(5y)44.74%
NOV.DE Yearly ROA, ROE, ROICNOV.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

1.3 Margins

  • With an excellent Profit Margin value of 33.14%, NOV belongs to the best of the industry, outperforming 98.04% of the companies in the same industry.
  • In the last couple of years the Profit Margin of NOV has remained more or less at the same level.
  • Looking at the Operating Margin, with a value of 41.30%, NOV belongs to the top of the industry, outperforming 94.12% of the companies in the same industry.
  • NOV's Operating Margin has been stable in the last couple of years.
  • NOV has a Gross Margin of 80.98%. This is amongst the best in the industry. NOV outperforms 84.31% of its industry peers.
  • In the last couple of years the Gross Margin of NOV has remained more or less at the same level.
Industry RankSector Rank
OM 41.3%
PM (TTM) 33.14%
GM 80.98%
OM growth 3Y-1.15%
OM growth 5Y-0.81%
PM growth 3Y1.84%
PM growth 5Y-0.03%
GM growth 3Y-1.18%
GM growth 5Y-0.61%
NOV.DE Yearly Profit, Operating, Gross MarginsNOV.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. NOV.DE Health Analysis

2.1 Basic Checks

  • NOV has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • Compared to 1 year ago, NOV has about the same amount of shares outstanding.
  • NOV has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, NOV has a worse debt to assets ratio.
NOV.DE Yearly Shares OutstandingNOV.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B
NOV.DE Yearly Total Debt VS Total AssetsNOV.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100B 200B 300B 400B 500B

2.2 Solvency

  • NOV has an Altman-Z score of 3.15. This indicates that NOV is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.15, NOV is in line with its industry, outperforming 50.98% of the companies in the same industry.
  • The Debt to FCF ratio of NOV is 4.52, which is a neutral value as it means it would take NOV, 4.52 years of fcf income to pay off all of its debts.
  • NOV has a Debt to FCF ratio (4.52) which is in line with its industry peers.
  • NOV has a Debt/Equity ratio of 0.61. This is a neutral value indicating NOV is somewhat dependend on debt financing.
  • NOV has a Debt to Equity ratio (0.61) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 4.52
Altman-Z 3.15
ROIC/WACC4.92
WACC6.26%
NOV.DE Yearly LT Debt VS Equity VS FCFNOV.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B

2.3 Liquidity

  • A Current Ratio of 0.80 indicates that NOV may have some problems paying its short term obligations.
  • NOV has a Current ratio of 0.80. This is amonst the worse of the industry: NOV underperforms 84.31% of its industry peers.
  • NOV has a Quick Ratio of 0.80. This is a bad value and indicates that NOV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • NOV's Quick ratio of 0.57 is on the low side compared to the rest of the industry. NOV is outperformed by 84.31% of its industry peers.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.57
NOV.DE Yearly Current Assets VS Current LiabilitesNOV.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B 200B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. NOV.DE Growth Analysis

3.1 Past

  • NOV shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.77%.
  • The Earnings Per Share has been growing by 20.66% on average over the past years. This is a very strong growth
  • NOV shows a small growth in Revenue. In the last year, the Revenue has grown by 6.43%.
  • The Revenue has been growing by 19.48% on average over the past years. This is quite good.
EPS 1Y (TTM)1.77%
EPS 3Y23.52%
EPS 5Y20.66%
EPS Q2Q%-4.73%
Revenue 1Y (TTM)6.43%
Revenue growth 3Y20.43%
Revenue growth 5Y19.48%
Sales Q2Q%-7.63%

3.2 Future

  • Based on estimates for the next years, NOV will show a small growth in Earnings Per Share. The EPS will grow by 5.80% on average per year.
  • The Revenue is expected to grow by 4.07% on average over the next years.
EPS Next Y-3.96%
EPS Next 2Y-2.8%
EPS Next 3Y1.16%
EPS Next 5Y5.8%
Revenue Next Year-6.3%
Revenue Next 2Y-1.34%
Revenue Next 3Y1.18%
Revenue Next 5Y4.07%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NOV.DE Yearly Revenue VS EstimatesNOV.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100B 200B 300B
NOV.DE Yearly EPS VS EstimatesNOV.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

6

4. NOV.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • NOV is valuated reasonably with a Price/Earnings ratio of 10.31.
  • Based on the Price/Earnings ratio, NOV is valued cheaper than 82.35% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.91. NOV is valued rather cheaply when compared to this.
  • The Price/Forward Earnings ratio is 10.73, which indicates a very decent valuation of NOV.
  • Based on the Price/Forward Earnings ratio, NOV is valued cheaper than 82.35% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of NOV to the average of the S&P500 Index (23.69), we can say NOV is valued rather cheaply.
Industry RankSector Rank
PE 10.31
Fwd PE 10.73
NOV.DE Price Earnings VS Forward Price EarningsNOV.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, NOV is valued cheaper than 96.08% of the companies in the same industry.
  • NOV's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 27.76
EV/EBITDA 6.15
NOV.DE Per share dataNOV.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The excellent profitability rating of NOV may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.5
EPS Next 2Y-2.8%
EPS Next 3Y1.16%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. NOV.DE Dividend Analysis

5.1 Amount

  • NOV has a Yearly Dividend Yield of 5.12%, which is a nice return.
  • The stock price of NOV dropped by -36.42% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • Compared to an average industry Dividend Yield of 1.94, NOV pays a better dividend. On top of this NOV pays more dividend than 92.16% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, NOV pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.12%

5.2 History

  • On average, the dividend of NOV grows each year by 19.05%, which is quite nice.
Dividend Growth(5Y)19.05%
Div Incr Years1
Div Non Decr Years1
NOV.DE Yearly Dividends per shareNOV.DE Yearly Dividends per shareYearly Dividends per share 2024 2025 2026 2 4 6 8 10

5.3 Sustainability

  • 50.53% of the earnings are spent on dividend by NOV. This is a bit on the high side, but may be sustainable.
  • NOV's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP50.53%
EPS Next 2Y-2.8%
EPS Next 3Y1.16%
NOV.DE Yearly Income VS Free CF VS DividendNOV.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B
NOV.DE Dividend Payout.NOV.DE Dividend Payout, showing the Payout Ratio.NOV.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

NOV.DE Fundamentals: All Metrics, Ratios and Statistics

NOVO NORDISK A/S-B

FRA:NOV (4/9/2026, 5:29:42 PM)

31.76

-0.49 (-1.52%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-03
Earnings (Next)05-06
Inst Owners32.22%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap107.67B
Revenue(TTM)309.06B
Net Income(TTM)102.43B
Analysts67.57
Price Target49.38 (55.48%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.12%
Yearly Dividend1.56
Dividend Growth(5Y)19.05%
DP50.53%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.82%
Min EPS beat(2)-7.04%
Max EPS beat(2)1.39%
EPS beat(4)2
Avg EPS beat(4)-0.71%
Min EPS beat(4)-7.04%
Max EPS beat(4)3.94%
EPS beat(8)5
Avg EPS beat(8)1.01%
EPS beat(12)8
Avg EPS beat(12)1.47%
EPS beat(16)11
Avg EPS beat(16)1.68%
Revenue beat(2)1
Avg Revenue beat(2)-1.06%
Min Revenue beat(2)-3.19%
Max Revenue beat(2)1.07%
Revenue beat(4)1
Avg Revenue beat(4)-0.92%
Min Revenue beat(4)-3.19%
Max Revenue beat(4)1.07%
Revenue beat(8)3
Avg Revenue beat(8)0.15%
Revenue beat(12)6
Avg Revenue beat(12)0.52%
Revenue beat(16)9
Avg Revenue beat(16)0.84%
PT rev (1m)0%
PT rev (3m)-10.13%
EPS NQ rev (1m)-0.4%
EPS NQ rev (3m)0.38%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.97%
Revenue NQ rev (1m)2.68%
Revenue NQ rev (3m)-49.65%
Revenue NY rev (1m)-1.73%
Revenue NY rev (3m)-6.54%
Valuation
Industry RankSector Rank
PE 10.31
Fwd PE 10.73
P/S 2.6
P/FCF 27.76
P/OCF 6.76
P/B 4.15
P/tB 12.57
EV/EBITDA 6.15
EPS(TTM)3.08
EY9.7%
EPS(NY)2.96
Fwd EY9.32%
FCF(TTM)1.14
FCFY3.6%
OCF(TTM)4.7
OCFY14.8%
SpS12.2
BVpS7.66
TBVpS2.53
PEG (NY)N/A
PEG (5Y)0.5
Graham Number23.04
Profitability
Industry RankSector Rank
ROA 18.87%
ROE 52.79%
ROCE 39.01%
ROIC 30.79%
ROICexc 33.56%
ROICexgc 59.2%
OM 41.3%
PM (TTM) 33.14%
GM 80.98%
FCFM 9.38%
ROA(3y)22.39%
ROA(5y)22.95%
ROE(3y)67.23%
ROE(5y)67.14%
ROIC(3y)43.61%
ROIC(5y)44.74%
ROICexc(3y)50.94%
ROICexc(5y)53.03%
ROICexgc(3y)100.46%
ROICexgc(5y)105.49%
ROCE(3y)55.75%
ROCE(5y)58.53%
ROICexgc growth 3Y-22.89%
ROICexgc growth 5Y-7.78%
ROICexc growth 3Y-18.13%
ROICexc growth 5Y-11.63%
OM growth 3Y-1.15%
OM growth 5Y-0.81%
PM growth 3Y1.84%
PM growth 5Y-0.03%
GM growth 3Y-1.18%
GM growth 5Y-0.61%
F-Score5
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 4.52
Debt/EBITDA 0.79
Cap/Depr 409.94%
Cap/Sales 29.16%
Interest Coverage 37.34
Cash Conversion 79.59%
Profit Quality 28.3%
Current Ratio 0.8
Quick Ratio 0.57
Altman-Z 3.15
F-Score5
WACC6.26%
ROIC/WACC4.92
Cap/Depr(3y)363.9%
Cap/Depr(5y)282.93%
Cap/Sales(3y)21.19%
Cap/Sales(5y)15.43%
Profit Quality(3y)60.31%
Profit Quality(5y)79.23%
High Growth Momentum
Growth
EPS 1Y (TTM)1.77%
EPS 3Y23.52%
EPS 5Y20.66%
EPS Q2Q%-4.73%
EPS Next Y-3.96%
EPS Next 2Y-2.8%
EPS Next 3Y1.16%
EPS Next 5Y5.8%
Revenue 1Y (TTM)6.43%
Revenue growth 3Y20.43%
Revenue growth 5Y19.48%
Sales Q2Q%-7.63%
Revenue Next Year-6.3%
Revenue Next 2Y-1.34%
Revenue Next 3Y1.18%
Revenue Next 5Y4.07%
EBIT growth 1Y-4.76%
EBIT growth 3Y19.04%
EBIT growth 5Y18.51%
EBIT Next Year8.51%
EBIT Next 3Y5.92%
EBIT Next 5Y7.75%
FCF growth 1Y-58.38%
FCF growth 3Y-23.26%
FCF growth 5Y-0.6%
OCF growth 1Y-1.54%
OCF growth 3Y14.72%
OCF growth 5Y18.05%

NOVO NORDISK A/S-B / NOV.DE Fundamental Analysis FAQ

What is the fundamental rating for NOV stock?

ChartMill assigns a fundamental rating of 6 / 10 to NOV.DE.


Can you provide the valuation status for NOVO NORDISK A/S-B?

ChartMill assigns a valuation rating of 6 / 10 to NOVO NORDISK A/S-B (NOV.DE). This can be considered as Fairly Valued.


How profitable is NOVO NORDISK A/S-B (NOV.DE) stock?

NOVO NORDISK A/S-B (NOV.DE) has a profitability rating of 9 / 10.


What is the financial health of NOVO NORDISK A/S-B (NOV.DE) stock?

The financial health rating of NOVO NORDISK A/S-B (NOV.DE) is 3 / 10.


Can you provide the dividend sustainability for NOV stock?

The dividend rating of NOVO NORDISK A/S-B (NOV.DE) is 7 / 10 and the dividend payout ratio is 50.53%.